Skip to main content
Clinical Trials/NCT04920591
NCT04920591
Completed
Not Applicable

Efficacy of Doll thErapy Compared With Standard Treatment in the Control of Behavioral and Psychologic Symptoms and CaRegIver Burden of dEmentia

Centre Hospitalier Universitaire Vaudois1 site in 1 country104 target enrollmentJanuary 1, 2019
ConditionsDementia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dementia
Sponsor
Centre Hospitalier Universitaire Vaudois
Enrollment
104
Locations
1
Primary Endpoint
Incidence of behavioral and psychologic symptoms in dementia measured by Neuropsychiatric Inventory (NPI) scale and by the A.Di.Co scale
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Behavioral and psychologic symptoms in dementia (BPSD) are frequent and represent a burden for patients and caregivers, the use of a first line non-pharmacologic approach is highly recommended. DESCRIBE is a randomized controlled trial on the effect of doll therapy (DT) on BPSD in different clinical settings.

The investigators will enroll fifty-two nursing homes residents and 52 acute in-patients with dementia and BPSD. Subjects will be randomized to DT or standard treatment (ST), The investigators will measured agitation, delirium and caregiver burden with standard clinical scales at baseline and during treatment. Nursing home residents will be evaluated after 45 and 90 days of treatment, in-patients will be evaluated at baseline and at hospital discharge. In acute in-patients, a follow-up of 4 weeks after hospital discharge will be carried out in order to evaluate the effect of DT withdrawal.

Primary outcomes will be the reduction of BPSD and the reduction of professional caregiver burden Secondary outcome will be the reduction of delirium and of effect of family caregiver burden.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
January 31, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Patrizia D'Amelio

associated professor

Centre Hospitalier Universitaire Vaudois

Eligibility Criteria

Inclusion Criteria

  • age ≥65 years;
  • diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) ≥2;
  • presence of agitation and/or aggressiveness;
  • manual and visual abilities sufficient in order to interact with the doll.

Exclusion Criteria

  • age \<65 years;
  • refuse to participate;
  • mild forms of dementia (CDR\<2);
  • contraindication for DT as experience of mournful or traumatic events related to parental experience;
  • life expectancy lower than 3 months;
  • negative interaction with the doll.

Outcomes

Primary Outcomes

Incidence of behavioral and psychologic symptoms in dementia measured by Neuropsychiatric Inventory (NPI) scale and by the A.Di.Co scale

Time Frame: 10-45-90 days

Change in NPI and A.Di.Co scales

Change in professional caregivers burden measured by the Greutzner scale

Time Frame: 10-45-90 days

change in professional caregiver burden

Secondary Outcomes

  • Incidence of delirium measured by the Confusion assessment Method (CAM) scale(45 and 90 days)
  • Change in caregiver burden measured by the caregiver Burden Inventory (CBI)(28 days)

Study Sites (1)

Loading locations...

Similar Trials